Literature DB >> 32217193

Urinary 8-oxo-7,8-dihydroguanosine as a potential biomarker of frailty for elderly patients with cardiovascular disease.

Yao-Dan Liang1, Qian Liu2, Ming-Hui Du3, Zhen Liu4, Si-Min Yao3, Pei-Pei Zheng3, Yu-Hao Wan3, Ning Sun3, Ying-Ying Li3, Jun-Peng Liu3, Yao Luo3, Jian-Ping Cai5, Jie-Fu Yang6, Hua Wang7.   

Abstract

The diagnosis of frailty is usually subjective, which calls for objective biomarkers in clinical medicine. 8-oxo-7,8-dihydro-2'-deoxyguanosine (8-oxodGsn) and 8-oxo-7, 8-dihydroguanosine (8-oxoGsn) in urine are two aging biomarkers that have not been explored deeply in cases of frailty. A total of 508 elderly patients with cardiovascular disease (mean age 75.0 ± 6.5 years, 50.8% males) were enrolled consecutively. Frailty was assessed by the Fried phenotype (robust: 0 score; pre-frail: 1-2 scores; frail: 3-5 scores). The concentrations of 8-oxoGsn and 8-oxodGsn in urine were measured by improved ultra-high-performance liquid chromatography-mass spectrometry (UPLC-MS/MS). Urinary creatinine (Cre) was tested to correct the 8-oxoGsn and 8-oxodGsn levels. According to the Fried phenotype score, the proportions of robust, pre-frail, and frail subjects were 20.5% (104/508), 53.9% (274/508), and 25.6% (130/508), respectively. The urinary 8-oxoGsn/Cre (P < 0.001) differed significantly among these 3 groups, but the urinary 8-oxodGsn/Cre (P = 0.600) showed no marked difference. Univariate and multivariate logistic regression showed that the age (odds ratio [OR] = 1.090, P < 0.001), systolic blood pressure (OR = 0.981, P = 0.008), 8-oxoGsn/Cre (OR = 1.203, P = 0.007), hemoglobin (OR = 0.980, P = 0.007), and sodium (OR = 0.915, P = 0.044) were independently associated with frailty. The sensitivity and specificity to identify frailty were 53.08% and 71.96%, respectively, for 8-oxoGsn/Cre at the optimal cut-off value of 3.879 μmol/mol according to the maximal Youden index. Urinary 8-oxoGsn, as a recognized biomarker of RNA oxidation, is independently associated with frailty in elderly patients with cardiovascular disease. However, the urinary 8-oxodGsn shows no obvious correlation with frailty. To obtain a better diagnostic performance for frailty, more biomarkers from different pathophysiological pathways should be explored in the future.
Copyright © 2020. Published by Elsevier Inc.

Entities:  

Keywords:  8-OxoGsn; 8-OxodGsn; Biomarker; Frailty; Oxidative stress

Mesh:

Substances:

Year:  2020        PMID: 32217193     DOI: 10.1016/j.freeradbiomed.2020.03.011

Source DB:  PubMed          Journal:  Free Radic Biol Med        ISSN: 0891-5849            Impact factor:   7.376


  3 in total

1.  Biomarkers of nucleic acid oxidation - A summary state-of-the-art.

Authors:  Mu-Rong Chao; Mark D Evans; Chiung-Wen Hu; Yunhee Ji; Peter Møller; Pavel Rossner; Marcus S Cooke
Journal:  Redox Biol       Date:  2021-01-28       Impact factor: 11.799

2.  Urinary 8-OxoGsn as a Potential Indicator of Mild Cognitive Impairment in Frail Patients With Cardiovascular Disease.

Authors:  Si-Min Yao; Pei-Pei Zheng; Wei He; Jian-Ping Cai; Hua Wang; Jie-Fu Yang
Journal:  Front Aging Neurosci       Date:  2021-08-25       Impact factor: 5.750

3.  Role of a Urinary Biomarker in the Common Mechanism of Physical Performance and Cognitive Function.

Authors:  Shan Jiang; Ju Cui; Li-Qun Zhang; Zhen Liu; Yan Zhang; Yuan Shi; Jian-Ping Cai
Journal:  Front Med (Lausanne)       Date:  2022-02-18
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.